 FDA Asserts New Policy to Restrict Women’s Access to Bioidentical Hormones |
From the Site News Articles List |
 Related Articles
Options to Hysterectomy
Pre-Op Hysterectomy
Post-Op Hysterectomy
Hormone and Menopause
Intimacy after Hysterectomy
Fitness after Hysterectomy
GYN Cancer
Hysterectomy Stories
Ask A Doctor
Advertisement
Agency Warns Pharmacies Not to Compound Commonly Prescribed Hormone Treatments, Use the Term “Bio-identical”
January 9, 2008
MISSOURI CITY, Texas – In a series of warning letters to compounding pharmacies across the country, the Food and Drug Administration (FDA) has asserted a policy that would deny hundreds of thousands of women access to many commonly compounded bioidentical hormones, substituting its judgment for that of doctors. Wyeth Pharmaceuticals, the number one manufacturer of synthetic hormone products, petitioned the FDA to do so in October 2005. More than 70,000 doctors, patients, and pharmacists filed comments with the FDA opposing Wyeth’s petition, the vast majority of whom opposed the petition.
“Under this policy, patients will suffer while Wyeth profits,” said L.D. King, executive director of the International Academy of Compounding Pharmacists (IACP). “Thousands of doctors are making patient-by-patient decisions that compounded hormones are medically appropriate, sometimes because Wyeth’s products are found to be ineffective or produce side effects. This is a decision that should be left to doctors.”
In the letters, the FDA states that it will “halt” compounding of medications containing estriol, an estrogen produced by the human body. Estriol is one of the most widely prescribed hormones and is regularly compounded with other bio-identical hormones pursuant to doctors’ prescriptions for women suffering from symptoms of menopause.
Like many commonly prescribed drugs (e.g, Phenobarbital, quinine, tinidazole), estriol has a monograph from the U.S. Pharmacopeia (USP), but is not a component of an FDAapproved drug. When it passed the FDA Modernization Act in 1997, Congress clearly indicated that drugs with a USP monograph could be compounded.
The FDA also stated in its letters that pharmacies may not use the term “bio-identical” to characterize compounded hormone therapies, even though the chemicals used in such compounds are chemically identical to what is produced by the human body. Furthermore, manufacturers of drugs containing the same bio-identical hormones commonly use the term to characterize their products.
The chemical structure of these drugs is indisputable. Pharmacy compounding is a long-standing, state-regulated and medically vital practice. Millions of Americans have unique health needs that off-the-shelf prescription medicines
cannot meet. For them, customized, compounded medications prescribed or ordered by licensed physicians or veterinarians and mixed safely by trained, licensed compounding pharmacists are the only way to better health.
About IACP
The International Academy of Compounding Pharmacists (IACP) is a non-profit association founded in 1991 to protect and promote the art and skill of the compounding pharmacy profession. We represent more than 2,000 pharmacists, physicians, technicians and patients who are committed to the safe practice of pharmacy compounding. We are committed to ensuring the rights of physicians to prescribe, of pharmacists to prepare and of patients to take customized medications that meet their unique, individual needs.
# #
http://www.iacprx.org/site/DocServer...pdf?docID=3281
For HysterSisters Discussion of this press release: Click Here
Eric Heegaard, M.D.
14001 Ridgedale Drive
Minnetonka MN 55305
952-249-2000 |
Barbara Levy, M.D.
34503 Ninth Avenue S. #330
Federal Way WA 98003
253-838-3695 |
Brad Cohen, M.D.
2477 Route 516
Suite 103
Old Bridge NJ 08857
732-679-6900 |
Vincenzo Sabella, M.D.
7950 Floyd Curl Dr. Ste. 600
San Antonio TX 78229
210-615-8585 |
Theodore Vlachos, M.D.
3535 W 13 Mile Rd
Royal Oak MI 48073
248-551-1399 |
Sherri Levin, M.D.
929 Gessner Suite 2100
Houston TX 77024
713-464-4111 |
John Garofalo, M.D.
30 Stevens St. Ste A.
Norwalk CT 06850
203-855-3535 |
Brooke Slaton, M.D.
Omega Women's Center, LLC
1801 University Drive, Suite 201
Coral Springs FL 33071
(954)755-1411 |
Wilfredo R. Ramos, M.D.
5301 F Street, Suite 210
Sacramento CA 95819
(916) 453-3440 |
|
|
|
-- January NewsletterPost Hysterectomy Fitness and Health is the theme of our January, 2012 newsletter at HysterSisters.com. Visit this link [ More]...
Advertisement
 Helpful Links
|
|
|
Store »
Hysterectomy Checkpoints
